Participants
Inclusion Criteria
Patients eligible for the trial must comply with all of the following at randomisation:
-
18 to 98 years of age
-
People who have had an ischaemic or haemorraghic stroke at least 6 months prior to study start
-
Limited dorsiflexion ROM in the upper ankle joint on the hemiparetic side: maximum 0° active ROM; maximum 5° of passive ROM
-
Capability to independently transfer from a seating to a standing position without an assistive device - use of the hands is allowed
-
Ability to independently walk without an assistive device for at least 10 metres
-
Confirmation by the principle investigator (PI) of the study (medical clinician) that there are no contraindications connected to exposure to active training
Exclusion Criteria
Patients will be excluded from the study if they meet any of the following criteria:
-
Any contraindication to MT (ankle instability, ankle inflammation or traumas etc.)
-
Any not fully recovered injuries of the musculoskeletal system
-
Previous surgery in the lower extremity region leading to walking impairment due to orthopaedic reasons
-
Relevant ROM reduction of the hip or knee joints
-
Any cognitive or communication impairment hindering participation in this pilot study according to the study PI (dementia, severe aphasia, being under legal guardianship etc.)
-
Diabetes mellitus
-
Rheumatic diseases
-
Chronic pain treated by drug therapy
-
History of previous stroke with persistent, impairing neurological symptoms (defined by a Modified Rankin Scale score (mRS) (21) of ≥ 3)
-
Comorbidity hindering participation, according to the study PI (life expectancy < 12 months, cancer, severe heart insufficiency etc.)
-
mRS score ≥ 4
-
Pregnancy
-
Military service
Recruitment and informed consent
The study will be advertised using recruitment flyers at medical and physiotherapy practices within a 30 km radius of the study location, written informed consent being taken by a medical doctor as per German legislation. Additionally, a trained physiotherapist who holds a Master’s degree in musculoskeletal physiotherapy and is studying for another Master’s degree in neurological physiotherapy (KT) will explain the study intervention in detail. Oral and written information will be given in comprehensible lay language and questions answered regarding study procedures.
Randomisation, concealment of allocation and blinding
Randomisation will be stratified on age, the most relevant predictive factor for balance and mobility change in people post stroke (strata: under 70; 70 and over). Stratification will help ensure similarity between the intervention and control groups regarding age. A stratified block randomisation in permuted blocks of three or six with a random number generator will be performed (Sealed Envelope, London, UK). with details of blocking kept in a separate, unavailable document.
Allocation concealment will be performed to avoid allocation bias. Each participant will receive a unique identification number (ID). Based on the randomisation list, sequentially numbered sealed opaque envelopes including group allocation numbers A, B and C will be created for each stratum, given to participants in the order they are recruited. Participants will be asked not to discuss their allocation until study completion. The allocation sequence and sealed envelopes will be created by a researcher who is not involved in the study procedures (BS). Participants will be assessed for eligibility and enrolled by the chief investigator (FS) and assigned to the intervention or control groups by the care provider, a physiotherapist-researcher (KT). Outcome assessors (EB; EK) will be blinded to the group allocation of participants. It will not be feasible to blind the care provider. Participants will be blinded to the study hypotheses.
Interventions
Eligible patients will be randomised into one of three groups:
-
Participants in Group A (Gp A) will receive a 15-minute talocrural joint MT directed at the dorsiflexion before a 30-minute specific task-oriented mobility and balance training 2 times per week. Further, a 20-minute home-based ankle mobilisation and TOT programme 4 times per week, for 4 weeks.
-
Participants in Group B (Gp B) will receive a 45-minute specific task-oriented mobility and balance training 2 times per week. Further, a 20-minute homebased TOT programme 4 times per week, for 4 weeks.
-
Participants in Group C (Gp C) will receive no specific treatment.
All participants will receive their usual care. Interventions in groups A and B will be provided face-to-face by an experienced physiotherapist (KT). Participants will be asked to perform the homebased training on the intervention-free days only and given free choice of one rest day per week.
Manual Therapy
MT will be directed towards the upper ankle joint structures and aim to increase the dorsiflexion ROM. Two different talocrural mobilisation techniques will be used as shown in Fig. 2. Manipulation Terminology is described according to Mintken et al. (22).
Face-to-face task-oriented training
TOT will focus on activities involving mobility and dynamic balance. Activities will be based on the requirements of daily living, i.e avoiding or stepping over obstacles or picking-up objects from the ground. Participants will be timed while being instructed to perform the goal-oriented activities with as much effort and speed as possible. The number of repetitions (or objects moved) will be counted aloud by the physiotherapist researcher as motivation. Additionally, participants will be encouraged to put maximum effort into the TOT, while remaining comfortable. According to established principles of motor learning, all exercises should progress in difficulty. Moreover, participants can choose the task order from a predefined list. Between tasks, participants may rest for 45–60 seconds. Table 1 presents an intervention chart based on the template for intervention description and replication (TIDieR) checklist (23). Detailed information on the face-to-face and homebased intervention is provided in Additional File 2.
Table 1
ITEM NO
|
ITEM DESCRIPTION
|
1 BRIEF NAME
|
Group A
|
Group B
|
Group C
|
Upper ankle joint manual therapy (MT) & task-oriented mobility and balance training (TOT)
|
Task-oriented mobility and balance training (TOT)
|
Control group: no intervention
|
2 WHY
|
To evaluate the feasibility of the methods, of a larger trial and explore the preliminary effects of a specific TOT versus its combination with talocrural MT on balance, mobility, ankle range of motion (ROM), number of falls and health-related quality of life in people post stroke.
|
3 WHAT MATERIALS
|
- Information sheet on study procedures
- Information booklet on homebased TOT programme
- Exercise diary including a compliance checklist
|
4 WHAT PROCEDURES
|
- Usual care
|
- TOT introduction: in lay language; description of the principles
- Supervised TOT performance
- Homebased TOT
|
|
- MT introduction: in lay language; description of the principles
- MT performance of the talocrural joint
- Homebased ankle mobilising exercise
|
|
|
5 WHO PROVIDES
|
The intervention will be provided by a trained physiotherapist who holds a Master’s degree in musculoskeletal physiotherapy and is studying for another Master’s degree in neurological physiotherapy
|
|
6 HOW
|
- TOT and MT introduction and performance: individually and depending on the group participants will be allocated to
- Homebased training: individually
|
|
7 WHERE
|
- TOT and MT introduction and performance: at Outpatient therapy centre „Kinema“, Germany
- Homebased training: At participants’ homes
|
|
17 minutes, 6 times a week, for 4 weeks
|
8 WHEN AND HOW MUCH
|
15 min MT plus 30 min TOT, 2 times per week, for 4 weeks
|
45 min TOT, 2 times per week, for 4 weeks
|
|
20 min homebased training, 4 times per week, for 4 weeks; on the supervised intervention-free days
|
|
9 TAILORING
|
Same intervention for all participants
|
Same intervention for all participants
|
No intervention
|
10 MODIFICATIONS
|
No modifications
|
No modifications
|
No modifications
|
11 HOW WELL PLANNED
|
- Intervention adherence and compliance will be assessed using a participant diary, during appointments and at post-intervention
- Recording in excel sheets will be performed by the instructing researcher (physiotherapist)
- The process will be supervised by the academic supervisor.
|
12 HOW WELL ACTUAL
|
- Adherence rates will be reported as median (range) times per week and percentage (95% confidence interval): face-to-face and homebased training
- Compliance will be presented narratively (exercise types and order; number of repetitions; problems and deviations from protocol with reasons or explanations)
|
Homebased training
The same homebased TOT programme will be used for participants in groups A and B. Participants will be informed they may select the TOT type and order but should alternate tasks over the intervention period. Tasks should be performed in sets of 3, E.g, (Task 2, Task 5, Task 7 and Task 8)*3. Gp A will receive a self-mobilisation technique of the upper ankle joint. Participants will be instructed to commence their training with self-mobilisation. Participants in Gp B will perform another task-oriented exercise. Participants will be instructed to record their training in an exercise diary e.g., number of repetitions/time period. Similar to face-to-face training, training will progress in difficulty. A 1-minute pause will be scheduled between the various tasks, but not between sets of the same task (Additional File 2).
Strategies to improve adherence to interventions
A 4-week goal-oriented face-to-face intervention will be used. Goal setting and supervision of exercises by a physiotherapist have been shown to facilitate adherence (24). The study intervention will be based on ADL relevant to people post stroke which may enhance adherence. In addition, the described TOT could be motivating for study participants. The 1:1 treatment sessions will be scheduled at the patients’ convenience.
As for home-based training, simple exercise instructions written in lay language and including photos will be employed to guide and improve training adherence. Participants will be allowed to freely choose the time, task order and type, however all tasks should be trained. Tasks will be demonstrated and explained by the physiotherapist. The scheduled duration of the home-based training is 20 minutes, likely perceived doable by participants. An exercise diary with a compliance checklist will be used to monitor adherence and checked by the physiotherapist weekly throughout the intervention period. as will adherence to the twice weekly sessions. Participants will be reminded of their post-intervention and follow-up appointments.
Data collection
Demographic (gender, age) and stroke specific data (lesion side; disease duration; modified Rankin scale score) will be extracted from patients’ charts at eligibility screening (-t1). Study specific assessment data will be collected at baseline (t1), post-intervention (t2) and follow-up (t3) at 4 weeks after completion (Table 3) by two physiotherapists blinded to the study intervention. Assessments will be performed at similar times to increase comparability. In addition to ROM measurement, the validated German version of all assessments will be used. Semi-structured interviews will gather in-depth information regarding acceptance of the study intervention. Changes from baseline and from post-intervention will be evaluated for all outcomes using means, medians, proportions and text as appropriate.
Table 3
Schedule of enrolment, intervention and data collection
|
STUDY PERIOD
|
|
Enrolment
|
Allocation
|
Post-allocation
|
|
Screening
|
|
Pre-test
Day 1
|
Post-test
Week 4
|
Follow-up
Week 8
|
TIMEPOINT
|
-t1
|
0
|
t1
|
t2
|
t3
|
ENROLMENT
|
|
Eligibility screen
|
X
|
|
|
|
|
Informed consent
|
X
|
|
|
|
|
Allocation
|
|
X
|
|
|
|
INTERVENTIONS
|
|
Intervention A
|
|
|
|
|
|
Intervention B
|
|
|
|
|
|
Control C
|
|
|
|
|
|
OUTCOMES
(ASSESSMENTS)
|
|
Baseline variables
|
|
Demographics
|
X
|
|
X
|
|
|
Clinical characteristics
Modified Rankin Scale
|
X
|
|
X
|
|
|
Primary outcomes
|
|
Feasibility
|
|
|
|
|
|
Recruitment rate
|
|
|
X
|
X
|
X
|
Retention rate
|
|
|
|
|
X
|
Adherence rate
|
|
|
X
|
X
|
X
|
Adverse events and falls
|
|
|
|
X
|
X
|
Compliance with the home exercise programme
|
|
|
|
X
|
|
Acceptability of the intervention
(Individual semi-structured interviews)
|
|
|
|
X
|
|
Key secondary outcome
|
|
Dynamic balance
(Mini BESTest)
|
|
|
X
|
X
|
X
|
Other secondary outcomes
|
|
Walking speed
(10-Metre Walk Test)
|
|
|
X
|
X
|
X
|
Functional mobility
(Timed Up and Go, TUG)
|
|
|
X
|
X
|
X
|
Dual-task functional mobility
(TUGmanual, TUGcognitive)
|
|
|
X
|
X
|
X
|
Passive ankle mobility
(DF and PF range of motion measures)
|
|
|
X
|
X
|
X
|
Active ankle mobility
(DF and PF range of motion measures)
|
|
|
X
|
X
|
X
|
Weightbearing ankle mobility
(DF range of motion measures)
|
|
|
X
|
X
|
X
|
Disability & health-related quality of life
(Stroke Impact Scale, version 2.0
|
|
|
X
|
X
|
X
|
Mini BESTest Mini Balance Evaluation Systems Test, DF dorsiflexion, PF plantarflexion |
Primary outcome
Feasibility
a. Recruitment, retention and adherence rates
The feasibility of conducting a full-scale RCT will be explored using predefined criteria, recording monthly recruitment and adherence rates to the face-to-face intervention. Using an exercise diary, adherence to the home exercise programme and any non-adherence will be recorded, including reasons (e.g., discontinuation due to lack of interest or injury). Any non-retention will also be recorded with reasons (e.g., consent withdrawn) (Fig. 1).
The criteria for feasibility success will be:
-
a target recruitment rate of 25% of 145 eligible patients (or 6 participants per month). The number of 145 was estimated according to information received from neurologists and clinicians practicing within 30 km of the study centre, concerning the number of eligible chronic stroke patients they have treated within the previous 9 months,
-
a target retention rate of 85%,
-
a target minimum adherence rate of 75% for face-to-face interventions (6 practice sessions per week out of a maximum of 8) and
-
a target minimum adherence rate of 75% for home-based interventions (12 practice sessions per week out of a maximum of 16).
b. Compliance with the home exercise programme
An exercise diary will be used to report compliance. Participants in groups A and B will be asked to complete an exercise diary recording type order and repetitions performed of chosen exercises. They should also explain any problems or deviations from the home exercise protocol.
c. Adverse events and falls
Falls are considered a relevant outcome from a mobility and balance intervention study because of the associated injury risk. Any adverse events and side effects will be systematically recorded and evaluated using a formal log including the type of adverse event, dates, severity, causality differentiated into serious/non-serious, actions to restore or improve the patient’s wellbeing and outcome of the event. A falls log will be provided to participants, which will be collected at t2 and t3, in addition to the number of and reasons for falls within prior 6 months. Study related adverse events will be treated and paid for. Severe adverse events will lead to early study termination.
d. Acceptability of the intervention
Acceptability of the intervention will be assessed using semi-structured qualitative interviews comprising four predefined questions presented in Table 2, utilised to learn how the interventions worked for the participants and how well they were appreciated. This is of clinical relevance because high acceptability may help increase motivation, autonomy and adherence in participants.
Table 2
Semi-structured interview guide
Introduction
|
Main part
|
|
Question #1
|
Would you please describe your experiences with the training in this study?
|
Question #2
|
Is there anything that would motivate you to further participate in this training (i.e., after the study)?
|
Question #3
|
What do you think about continuing with the home-exercise programme?
|
Question #4 (Gp A)
|
How did you experience the manual therapy of your foot?
|
Question #4 (Gp B)
|
How was the duration of the training for you?
|
Prompt #1
|
Why so?
|
Prompt #2
|
Could you describe this in more detail?
|
Thanks & Conclusion
|
Many thanks for participating in this interview.
|
Adapted from (59) and (60). |
Key secondary outcome
Dynamic balance (Mini Balance Evaluation Systems Test, Mini BESTest)
The primary outcome will be dynamic balance as assessed by the Mini Balance Evaluation Systems Test (BESTest) (25). Fourteen items are rated on a 3-point ordinal scale (from 0 = severe to 2 = normal). A transformation table from raw into interval scores is available since the Mini BESTest demonstrated excellent construct validity, unidimensionality, minimal ceiling and no floor effects (25) and a minimal detectable change of 3.0 points (26). The 4 subscales are transitions/anticipatory postural control, reactive postural control, sensory orientation and stability in gait. Preliminary changes in the key secondary outcome will be used to calculate the sample size for the main trial.
Other secondary outcomes
Participants may use their walking aid for all walking tests, but this needs to be documented and used consistently for all trials.
a. Walking speed (10-Metre Walk Test, 10MWT)
The 10MWT at maximum speed will be used as a functional measure of walking. It has been recommended by various task forces (27, 28). Academy of Neurologic Physical Therapy test instructions will be followed and data recorded in m/s. The average will be calculated from two trials.
For the 10MWT, an excellent concurrent validity has been shown with ADL (29). Good convergent validity with the 6-Minute Walk Test (30) has been observed, an excellent interrater and test-retest reliability and a minimum detectable change (MDC) of 16% (31).
b. Functional mobility (Timed Up and Go, TUG)
The TUG (32) is a measure of functional mobility able to detect change over time in patients post stroke (31). The participant is observed and timed while he or she rises from a chair with armrests, walks 3 metres as quickly and safely as possible towards a marking, turns, walks back and sits. Excellent interrater reliability has been found, plus good convergent validity with relevant measures (32). The MDC of the TUG in stroke patients is 23% (31).
c. Functional mobility with dual tasking (TUGmanual and TUGcognitive)
Dual tasking will be assessed using the TUGmanual and TUGcognitive where the TUG is combined with a motor (carrying) or cognitive task (subtracting in threes) (33). For both dual-tasking TUGs, a good test-retest reliability and convergent validity have been confirmed (34, 35). An MDC of 3.53 seconds for the TUGmanual (34) has been observed in people after stroke. The time difference between the TUG and TUGcognitive is indicative of an increased fall risk (36).
d. Ankle range of motion (passive and active dorsiflexion and plantarflexion ROM)
Ankle mobility will be assessed using different techniques to assess the effects of MT.
1. Non-weightbearing dorsiflexion and plantarflexion ROM measurement
Passive and active talocrural dorsiflexion (DF) and plantarflexion (PF) ROM will be assessed in non-weight-bearing supine position with the knees on a standard knee roll (20° flexed), to avoid tensioning of the gastrocnemius muscle (37). A standard measurement technique is described in detail in Additional File 3. Data will be recorded using the neutral-zero method (38). Excellent interrater reliability has been demonstrated for ankle dorsiflexion (37) and plantarflexion measures (39).
2. Weightbearing dorsiflexion ROM measurement
Ankle dorsiflexion ROM will also be assessed utilising a tape measure and a weight-bearing lunge facing a wall, as validated by Konor et al. (2012) and outlined in detail in Additional File 3 (40). Excellent interrater (41) and intrarater reliability, low measurement error and an MDC of 1.1–1.5 cm has been demonstrated for this measurement technique (40).
e. Disability and HRQoL after stroke (Stroke Impact Scale, version 2.0, SIS v2.0)
The validated German version (42) of the SIS v2.0 (43) will be used to assess disability and HRQoL. The SIS is a stroke-specific PROM comprising 64 items and assessing 8 domains (strength, memory, emotion, communication, ADL and instrumented ADL (IADL), mobility, hand function, and social participation). A summary score is not calculated, but a physical domain score can be created from the strength, hand function, mobility and ADL/IADL domains. In the emotion domain, items 3a-e and 3 g are reverse scored, with all items scored on a 5-point Likert scale. Scores for each domain are transformed to a 0-100 score with lower scores representing poor HRQoL; using the formula: Transformed Scale = [(Actual raw score - lowest possible raw score) / Possible raw score range] * 100. In addition, the SIS v2.0 includes a 0-100 visual analogue scale, with 0 representing no recovery and 100 representing full recovery.
Moderate to excellent internal consistency, test-retest reliability, convergent, divergent and discriminant validity have been demonstrated for the SISv2 (43).
Participant timeline
The planned study duration is from 11.9.2020 to 31.5.2021. A detailed overview of the participant timeline is shown in Table 3.
Sample size
The study will be a pilot RCT to provide information for a subsequent larger RCT. The sample size was based on specific objectives of the study such as feasibility, acceptability and falls rather than on estimated effects of interventions. Julious recommends a minimum sample size of 12 participants per group for pilot studies (44). Therefore, 36 people post stroke will be recruited into three groups (A, B and C) For the sample size estimation, imprecision of the standard deviation in small samples will be taken into account (45).
Data management and data protection
Data quality will be promoted by duplicate (10MWT) or triple measurements (ankle ROM measures, utilising two different measurement approaches). Only the PI and care provider will be aware of the demographic data and have access to the pseudonymisation documents. Double data entry will be performed. Data will be verified by conducting spot checks of value ranges and field types for certain data fields, and logical checks will also be performed (e.g. the order of visits). When checking value ranges, the fields will be checked for permitted values. Field type checks concern whether the values entered fit the field definition (e.g. numerical fields). Any discrepancies found will be rectified.
For the qualitative analysis of interviews, coding will be performed by two independent coders (KT, BS). Codes will be discussed and if a consensus cannot be reached, a third researcher will provide support (FS). Post interview, the interviewer will review and ascertain that all answers have been understood correctly. Participants will be asked to provide feedback on the findings. For the report, participant quotations will be used, together with participant ID and group allocation.
German legislation states any study records and documents must be stored for a period of 10 years after the conclusion of the clinical study. Personal data will be collected, forwarded, stored and evaluated as part of this clinical study in accordance with the legal provisions of the General Data Protection Regulation (EU) 2016/679 (GDPR) and German Data Protection Act 2018 (BDSG).
Statistical analysis
IBM SPSS Software, release 26.0 (IBM Corporation, Armonk, NY, USA) and GraphPad Prism 8, San Diego, California, will be used for the data analyses. Statistical significance will be defined as a two-tailed p-value < 0.05. The percentage of missing data will be recorded. Using Little’s test of missing completely at random (MCAR) (46) the data will be checked, signified by a p-value > 0.05. An intention-to-treat analysis will be performed.
Descriptive statistics will be used for the baseline demographic variables, primary and secondary outcomes. Continuous data will be checked for normal distribution using the Shapiro Wilk Test, Q-Q plots and histograms. Raw count (number (N), %) will be presented for counted (N females and males, N falls and N adverse events if any, compliance (types and order of home exercises, N of repetitions and deviations from the protocol) and nominal data (gender, recruitment, retention and adherence rates). Medians (range; 25th and 75th percentiles) will be reported for ordinal data (Mini BESTest if there are missing data, SIS), mean (95% confidence interval (CI)) will be reported for continuous data (age, Mini BESTest if data can be transformed into interval level, 10MWT, TUG, TUGmanual, TUGcognitive, ankle ROM measures).
The recruitment rate (%) will be estimated by dividing the number of consenting participants by the N of eligible patients, multiplied by 100. The retention rate determined by dividing the N of participants who completed the study by the N of the total sample, times 100. Adherence rates will be calculated by dividing the N of TOT sessions (8x; 16x) performed by the participants, divided by the N of the scheduled (face-to-face; home-based) training sessions over the 4 week study period, times 100 (47). The eligibility, recruitment and adherence rates will be calculated with their 95% CI according to the Wilson ‘score’ method cited by Newcombe (48); when the proportion is close to 0 or 1, a Poisson approximation as described by Brown and colleagues will be used (49).
Inductive statistics will detect any trends related to the intervention efficacy acting as a basis for the sample size calculation for a larger main study. The sample size estimation will be based on a power of 80%, an alpha of 5% and the standardised effect size (Cohen’s d). Cohen’s d will be calculated using the formula d = (mean 1 − mean 2)/corrected pooled SD. The corrected pooled SD for 80% of trials will be determined using the formula (square root from ((SD12 + SD22)/2))*1.293 (45). Effect sizes will be estimated with 95% CI using an effect size calculator provided by the Centre for Evaluation and Monitoring at the University of Durham, UK.
Baseline group differences will be examined using Chi-square test for nominal data, Kruskal Wallis test for ordinal data and one-way analysis of variance (ANOVA) for continuous data. If a non-normal data distribution is observed in continuous data, data transformation or non-parametrical tests will be performed, as appropriate. Kruskal Wallis test will evaluate differences between groups and timepoints, followed by a Bonferroni correction for multiple comparisons. On continuous data, test assumptions for a mixed design ANOVA will be reviewed, with standard correction procedures employed appropriately. In order to evaluate the effects of the intervention on walking speed, mobility, dual-task mobility and ankle ROM, a 2-way mixed design ANOVA will be used, with “time” (t1, t2 and t3) as within-subject factor and “group” (A, B and C) as between-subject factor. If the overall group-by-time interaction is statistically significant, post-hoc tests with Bonferroni correction will be applied to determine group differences in pairwise comparisons.
Qualitative data analysis
Interviews will be transcribed applying the Dresing and Pehl (2017) transcription rules (50) using F4 Transkript software (Dr. Dresing & Pehl GmbH, Marburg, Germany). Data analysis will be conducted with MaxQDA software (VERBI GmbH, Berlin, Germany) adhering to the Consolidated Criteria for Reporting Qualitative Research (COREQ) (51). Qualitative content analysis will use a systematic and consistent approach to enhance rigour (52–54).
Coding of the total dataset will be performed by two independent researchers to increase intersubjective conformability (55). Recurring ideas, concepts, themes and words will be identified. A combined inductive and deductive category development approach, based on the material and the research question will be used. A coding frame where categories are required to be (apparently) unidimensional, mutually exclusive and exhaustive will be developed. Each dimension should capture a different concept of the text. Relevant material will be selected, structured and marked, text sections segmented to identify main and subcategories. Categories will be defined, named and characterised. Subcategory saturation indicated after one use. A minimum length of a segment is one sentence. Categories will be continuously adapted (54). A data matrix will be created and descriptive statistics performed e.g., frequencies. Categories and subcategories will be illustrated using quotations together with a participant ID and group number (A, B or C). Credibility will be further enhanced through a reflective diary for documenting decisions (reflexivity) and peer debriefing of the interviewer to identify biases and assumptions (truth value) (55). Records will be kept carefully to ensure consistent and transparent data interpretation (56). Comparisons across accounts will be sought to ensure various perspectives are represented (57).
Dissemination